Evidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early Alzheimer's disease

scientific article published on 8 October 2013

Evidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early Alzheimer's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000351864
P8608Fatcat IDrelease_3ea7dra375gwtg4vhm5r3gwlge
P698PubMed publication ID24107412

P50authorAna Sofia CostaQ45722281
Jörg B. SchulzQ52088891
Kathrin ReetzQ40125730
P2093author name stringArno Reich
Bruno Fimm
Simon Thomas Ketteler
P2860cites workMild cognitive impairment in symptomatic and asymptomatic cerebrovascular diseaseQ48258228
Montreal Cognitive Assessment: influence of sociodemographic and health variablesQ48745434
Deterioration of visual-perceptual organization ability in Alzheimer's diseaseQ48900093
Official position of the american academy of clinical neuropsychology on serial neuropsychological assessments: the utility and challenges of repeat test administrations in clinical and forensic contextsQ50691804
Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive impairment 3-6 months after stroke.Q50761901
Validation studies of the Portuguese experimental version of the Montreal Cognitive Assessment (MoCA): confirmatory factor analysis.Q51860172
A total score for the CERAD neuropsychological battery.Q51928190
Revising the definition of Alzheimer's disease: a new lexicon.Q53313597
Alternate-form reliability of the Montreal cognitive assessment screening test in a clinical setting.Q53330739
Revised research diagnostic criteria for Alzheimer's disease.Q53394473
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.Q55053125
Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up studyQ28728080
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteriaQ29614408
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairmentQ29615678
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlatesQ33591798
Methods for assessing responsiveness: a critical review and recommendationsQ33919427
Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center databaseQ33924622
Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sampleQ34019643
The MoCA: well-suited screen for cognitive impairment in Parkinson disease.Q34024621
Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression studyQ35004787
Visual assessment of posterior atrophy development of a MRI rating scaleQ35552599
A longitudinal study of language decline in Alzheimer's disease and frontotemporal dementiaQ38399595
Measuring cognition in a geriatric outpatient clinic: Rasch analysis of the Montreal Cognitive AssessmentQ43683733
Changes on brief cognitive instruments over time in Parkinson's diseaseQ43843579
P433issue1-2
P921main subjectAlzheimer's diseaseQ11081
P304page(s)95-103
P577publication date2013-10-08
P1433published inDementia and Geriatric Cognitive DisordersQ15749436
P1476titleEvidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early Alzheimer's disease
P478volume37

Reverse relations

cites work (P2860)
Q55072113Change in Cognition and Other Non-Motor Symptoms With Obstructive Sleep Apnea Treatment in Parkinson Disease.
Q38636474Cognitive Improvement and Brain Changes after Real-Time Functional MRI Neurofeedback Training in Healthy Elderly and Prodromal Alzheimer's Disease
Q36751172Comparison of Alternate and Original Items on the Montreal Cognitive Assessment.
Q45297926Evaluating Recall and Recognition Memory Using the Montreal Cognitive Assessment: Applicability for Alzheimer's and Huntington's Diseases
Q36688859Outcome measures for Parkinson's disease dementia: a systematic review
Q57809539Postoperative cognitive dysfunction after cochlear implantation
Q35674661Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease.
Q36298580Sensitivity to change and prediction of global change for the Alzheimer's Questionnaire
Q47393517Trajectory and variability characterization of the Montreal cognitive assessment in older adults
Q57039646White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients
Q36809236Working Memory Network Changes in ALS: An fMRI Study
Q50745557[Trail walking test for assessment of motor cognitive interference in older adults. Development and evaluation of the psychometric properties of the procedure].

Search more.